| Current Price | $10.21 | Mkt Cap | $262.5M |
|---|---|---|---|
| Open | $10.44 | P/E Ratio | 0.00 |
| Prev. Close | $10.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $10.11 - $10.44 | Volume | 14,704 |
| 52-Wk Range | $9.38 - $15.33 | Avg. Daily Vol. |
| Current Price | $10.21 | Mkt Cap | $262.5M |
|---|---|---|---|
| Open | $10.44 | P/E Ratio | 0.00 |
| Prev. Close | $10.26 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $10.11 - $10.44 | Volume | 14,704 |
| 52-Wk Range | $9.38 - $15.33 | Avg. Daily Vol. |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(70.28)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-105.87
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-133.62
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-136.16
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
naughtyguy (35.45) Score: +166.55
No products in their pipeline that have reached phase 3. This usually means a long time before any money is made and going through a lot of cash needing to offer more stock for sale to raise cash. Investors will be impatient and invest elsewhere.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 39.34 | 3/20/2015 |
|
NS | $405.00 | -97.47% | +39.10% | +136.56 | 0 Comment | |
| WSMOOT19 | 71.90 |
|
|
1Y | $40.05 | -74.38% | +39.47% | +113.85 | 0 Comment | |
| IdahoInvestor | 43.81 | 8/17/2015 |
|
5Y | $15.75 | -34.86% | +39.93% | +74.78 | 0 Comment | |
| Playa14 | < 20 | 1/16/2018 |
|
5Y | $8.48 | +21.00% | +4.93% | +16.08 | 0 Comment | |
| BigDreamer | 46.08 | 1/29/2018 |
|
3Y | $8.95 | +14.64% | +2.14% | +12.50 | 0 Comment | |
| drcor | 32.64 | 1/23/2018 |
|
3M | $8.90 | +15.28% | +3.05% | +12.23 | 0 Comment | |
| hayrettin | 70.58 | 2/5/2018 |
|
5Y | $8.55 | +20.00% | +7.97% | +12.03 | 0 Comment | |
| skyrocket29 | 55.07 | 1/16/2018 |
|
3M | $9.10 | +12.75% | +4.39% | +8.35 | 0 Comment | |
| portefeuille | 98.28 | 3/22/2018 |
|
5Y | $9.95 | +3.12% | +9.55% | -6.43 | 0 Comment | |
| jeepdrew222 | 64.51 | 8/28/2018 |
|
5Y | $12.90 | -20.47% | +0.60% | -21.06 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
| Player Name | Player Rating |
Start Date |
Call | Time Frame |
Start Price |
Stock Gain |
S&P Gain |
Score | End Date | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TrackJimCramer | 86.58 | 3/20/2015 |
|
3W | $394.20 | -97.40% | +38.80% | -136.19 | 0 Comment | |
| TrackBWS | 96.39 | 3/19/2014 |
|
NS | $197.25 | +13.76% | +3.89% | +9.88 | 6/18/2014 @ $224.40 | 0 Comment |
| TrackBarclaysCap | 88.62 | 2/24/2014 |
|
NS | $137.55 | -92.54% | +58.48% | -151.02 | 0 Comment |
